PRESS RELEASE published on 04/14/2026 at 17:50, 5 months 3 days ago FURTHER STRONG GROWTH IN ANNUAL RESULTS FOR THE 2025 FINANCIAL YEAR Diagnostic Medical Systems (DMS) reports strong growth in 2025 financial results with revenue reaching €50 million, +8.5% YoY. Dynamic EBITDA growth of +69% and positive net income. Outlook focuses on outperforming the medical imaging market Financial Results Outlook Growth Diagnostic Medical Systems Medical Imaging Market
BRIEF published on 04/14/2026 at 17:50, 5 months 3 days ago DMS Group's Annual Performance and Results for 2025 Financial Results EBITDA Organic Growth International Expansion Medical Imaging
BRIEF published on 04/13/2026 at 14:35, 5 months 4 days ago DMS Group videoconference: Key information for investors Financial Results Shareholders Investors Medical Imaging Vidéo Conférence
BRIEF published on 04/07/2026 at 18:10, 5 months 10 days ago DMS Group Achieves European MDR Certification for STRATOS Densitometers Revenue Growth MDR Certification Imaging Solutions US Market Entry STRATOS Densitometers
BRIEF published on 04/07/2026 at 18:05, 5 months 10 days ago European MDR certification for DMS Group International Expansion American Market MDR Certification DMS Group Bone Densitometers
PRESS RELEASE published on 04/07/2026 at 18:05, 5 months 10 days ago DMS GROUP OBTAINS EUROPEAN MDR CERTIFICATION FOR ITS STRATOS BONE DENSITOMETER RANGE Diagnostic Medical Systems (DMS) obtains MDR certification for bone densitometers, confirming compliance with EU medical device regulations. Strategic expansion into US market planned Regulatory Compliance MDR Certification US Market Expansion Diagnostic Medical Systems Bone Densitometers
BRIEF published on 03/27/2026 at 07:35, 5 months 21 days ago DMS Group Secures €20 Million Financing from European Investment Bank Medical Imaging European Investment Bank DMS Group InvestEU Innovation Financing
BRIEF published on 03/27/2026 at 07:35, 5 months 21 days ago DMS Group secures strategic financing from the EIB Technological Innovation Medical Imaging DMS Group InvestEU EIB Financing
PRESS RELEASE published on 03/27/2026 at 07:30, 5 months 21 days ago DMS GROUP: THE EUROPEAN INVESTMENT BANK GRANTS A FINANCING LINE OF UP TO EUR 20 MILLION DMS Group secures up to €20 million financing from the European Investment Bank to boost the development of new medical imaging solutions and strengthen its position in the global market. The funding supports the company's innovation strategy and industrial expansion plans Financing European Investment Bank DMS Group Innovation Strategy Medical Imaging Solutions
BRIEF published on 03/03/2026 at 17:50, 6 months 14 days ago Update on voting rights for Diagnostic Medical Systems Share Capital Voting Rights Actions Euronext Growth Diagnostic Medical Systems
Published on 09/18/2026 at 00:55, 49 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 1 hour 19 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 3 hours 29 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 3 hours 29 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 3 hours 39 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 6 hours 44 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 6 hours 46 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 7 hours 19 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 7 hours 34 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 7 hours 58 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 8 hours 4 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 7 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 18 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification